Pharming Group N.V.
PHGUF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $675 | $796 | $749 | $532 |
| - Cash | $55 | $62 | $207 | $192 |
| + Debt | $112 | $172 | $167 | $162 |
| Enterprise Value | $732 | $906 | $708 | $502 |
| Revenue | $297 | $245 | $206 | $190 |
| % Growth | 21.1% | 19.3% | 8.3% | – |
| Gross Profit | $240 | $220 | $187 | $170 |
| % Margin | 80.7% | 89.7% | 90.9% | 89.4% |
| EBITDA | $14 | $10 | $34 | $49 |
| % Margin | 4.6% | 4% | 16.3% | 25.7% |
| Net Income | -$11 | -$11 | $14 | $16 |
| % Margin | -3.8% | -4.4% | 6.7% | 8.4% |
| EPS Diluted | -0.017 | -0.015 | 0.019 | 0.023 |
| % Growth | -12.7% | -178.9% | -17.4% | – |
| Operating Cash Flow | -$2 | -$17 | $23 | $36 |
| Capital Expenditures | -$1 | -$1 | -$2 | -$16 |
| Free Cash Flow | -$7 | -$19 | $21 | $20 |